Meeting Report Europhosphatase 2015: Phosphatases as Drug Targets in Cancer

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Abstract

Phosphatases are key regulators of cellular signaling and as such play an important role in nearly all cellular processes governing diseases, including cancer. However, due to their highly conserved structure and highly charged and reactive catalytic site, they have been regarded as "undruggable." Fortunately, during the recent Europhosphatase meeting (Turku, Finland), it became clear that phosphatases can no longer be ignored as potential targets in cancer therapy. As reactivation of tumor-suppressor phosphatases or direct inhibition of phosphatases acting as oncogenes is becoming available, this class of enzymes can now be considered as feasible drug targets. (C) 2016 AACR.
Original languageUndefined/Unknown
Pages (from-to)193-196
Number of pages4
JournalCancer Research
Volume76
Issue number2
DOIs
Publication statusPublished - 2016

Cite this